Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 9Erectile Dysfunction 9Sexuality 2Sexual Dysfunction, Physiological 2Rectal Neoplasms 2Neoplasms 2Fatigue 2Brain Neoplasms 2Waldenstrom Macroglobulinemia 1Vascular Malformations 1Urogenital Neoplasms 1Urinary Bladder Neoplasms 1Solid Tumor 1Sarcoma 1Radiation Injuries 1Pre-Eclampsia 1Postoperative Complications 1Penile Neoplasms 1Pancreatic Neoplasms 1Neurologic Manifestations 1Mental Fatigue 1Lymphoma, Follicular 1Lymphatic Abnormalities 1Lymphangioma 1Infertility 1Glioma 1Glioblastoma 1Gastrointestinal Neoplasms 1Erectile Dysfunction Following Radical Prostatectomy 1Cholangiocarcinoma 1

Interventions

mirdametinib 1Vincristine 1Timolol 1Sirolimus 1Sildenafil Citrate 1Ointments 1Mupirocin 1Lasers, Dye 1Everolimus 1Bioseal 1Alpelisib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Vascular Malformations × Sildenafil Citrate × Clear all
NCT01290484 2015-06-19

A Study to Evaluate Sildenafil for the Treatment of Lymphatic Malformations

Stanford University

Phase 1/2 Completed
7 enrolled 5 charts

Lymphangioma, Lymphatic Abnormalities, Vascular Malformations

Data powered by HemOnc (CC BY 4.0) Colophon âš¡